Autophagy-related genes affect the survival of multiple myeloma patients depending on chromosomal abnormality

[1] Mizushima N. Autophagy: process and function. Genes Dev. 2007; 21:2861–73. MizushimaN Autophagy: process and function Genes Dev 2007 21 2861 73 Search in Google Scholar

[2] Knaevelsrud H, Ahlquist T, Merok MA, Nesbakken A, Stenmark H, Lothe RA, Simonsen A. UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy. Autophagy. 2010; 6:863–70. KnaevelsrudH AhlquistT MerokMA NesbakkenA StenmarkH LotheRA SimonsenA UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy Autophagy 2010 6 863 70 Search in Google Scholar

[3] Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W, et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res. 2011; 17:654–66. AmaravadiRK Lippincott-SchwartzJ YinXM WeissWA TakebeN TimmerW Principles and current strategies for targeting autophagy for cancer treatment Clin Cancer Res 2011 17 654 66 Search in Google Scholar

[4] Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008; 132:27–42. LevineB KroemerG Autophagy in the pathogenesis of disease Cell 2008 132 27 42 Search in Google Scholar

[5] Lorin S, Hamaï A, Mehrpour M, Codogno P. Autophagy regulation and its role in cancer. Semin Cancer Biol. 2013; 23:361–7. LorinS HamaïA MehrpourM CodognoP Autophagy regulation and its role in cancer Semin Cancer Biol 2013 23 361 7 Search in Google Scholar

[6] White E, Karp C, Strohecker AM, Guo Y, Mathew R. Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol. 2010; 22:212–7. WhiteE KarpC StroheckerAM GuoY MathewR Role of autophagy in suppression of inflammation and cancer Curr Opin Cell Biol 2010 22 212 7 Search in Google Scholar

[7] Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 2007; 21:1367–81. MathewR KongaraS BeaudoinB KarpCM BrayK DegenhardtK Autophagy suppresses tumor progression by limiting chromosomal instability Genes Dev 2007 21 1367 81 Search in Google Scholar

[8] Saha S, Panigrahi DP, Patil S, Bhutia SK. Autophagy in health and disease: a comprehensive review. Biomed Pharmacother. 2018; 104:485–95. SahaS PanigrahiDP PatilS BhutiaSK Autophagy in health and disease: a comprehensive review Biomed Pharmacother 2018 104 485 95 Search in Google Scholar

[9] Kang MR, Kim MS, Oh JE, Kim YR, Song SY, Kim SS, et al. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol. 2009; 217:702–6. KangMR KimMS OhJE KimYR SongSY KimSS Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability J Pathol 2009 217 702 6 Search in Google Scholar

[10] Lu D, Yang C, Zhang Z, Cong Y, Xiao M. Knockdown of linc00515 inhibits multiple myeloma autophagy and chemoresistance by upregulating miR-140-5p and downregulating ATG14. Cell Physiol Biochem. 2018; 48:2517–27. LuD YangC ZhangZ CongY XiaoM Knockdown of linc00515 inhibits multiple myeloma autophagy and chemoresistance by upregulating miR-140-5p and downregulating ATG14 Cell Physiol Biochem 2018 48 2517 27 Search in Google Scholar

[11] MAQC Consortium. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol. 2010; 28:827–38. MAQC Consortium The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models Nat Biotechnol 2010 28 827 38 Search in Google Scholar

[12] Usmani SZ, Sexton R, Hoering A, Heuck CJ, Nair B, Waheed S, et al. Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance. Blood. 2012; 120:1597–600. UsmaniSZ SextonR HoeringA HeuckCJ NairB WaheedS Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance Blood 2012 120 1597 600 Search in Google Scholar

[13] Nahi H, Sutlu T, Jansson M, Alici E, Gahrton G. Clinical impact of chromosomal aberrations in multiple myeloma. J Intern Med. 2011; 269:137–47. NahiH SutluT JanssonM AliciE GahrtonG Clinical impact of chromosomal aberrations in multiple myeloma J Intern Med 2011 269 137 47 Search in Google Scholar

[14] Avet-Loiseau H, Li C, Magrangeas F, Gouraud W, Charbonnel C, Harousseau JL, et al. Prognostic significance of copy-number alterations in multiple myeloma. J Clin Oncol. 2009; 27:4585–90. Avet-LoiseauH LiC MagrangeasF GouraudW CharbonnelC HarousseauJL Prognostic significance of copy-number alterations in multiple myeloma J Clin Oncol 2009 27 4585 90 Search in Google Scholar

[15] Van Wier S, Braggio E, Baker A, Ahmann G, Levy J, Carpten JD, Fonseca R. Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma. Haematologica. 2013; 98:1586–92. Van WierS BraggioE BakerA AhmannG LevyJ CarptenJD FonsecaR Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma Haematologica 2013 98 1586 92 Search in Google Scholar

[16] Zhang Y, Chen XL, Chen WM, Zhou HB. Prognostic nomogram for the overall survival of patients with newly diagnosed multiple myeloma. Biomed Res Int. 2019; 8:5652935. doi: 10.1155/2019/5652935 ZhangY ChenXL ChenWM ZhouHB Prognostic nomogram for the overall survival of patients with newly diagnosed multiple myeloma Biomed Res Int 2019 8 5652935 10.1155/2019/5652935 Open DOISearch in Google Scholar

[17] Kumar S, Fonseca R, Ketterling RP, Dispenzieri A, Lacy MQ, Gertz MA, et al. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. Blood. 2012; 119:2100–5. KumarS FonsecaR KetterlingRP DispenzieriA LacyMQ GertzMA Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics Blood 2012 119 2100 5 Search in Google Scholar

[18] Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017; 67:93–9. AminMB GreeneFL EdgeSB ComptonCC GershenwaldJE BrooklandRK The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging CA Cancer J Clin 2017 67 93 9 Search in Google Scholar

[19] Zhang BH, Yang J, Jiang L, Lyu T, Kong LX, Tan YF, et al. Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma. Genomics. 2020; 112:2763–71. doi: 10.1016/j.ygeno.2020.03.013 ZhangBH YangJ JiangL LyuT KongLX TanYF Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma Genomics 2020 112 2763 71 10.1016/j.ygeno.2020.03.013 Open DOISearch in Google Scholar

[20] Hu D, Jiang L, Luo S, Zhao X, Hu H, Zhao G, Tang W. Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients. J Transl Med. 2020; 18:160. doi: 10.1186/s12967-020-02323-x HuD JiangL LuoS ZhaoX HuH ZhaoG TangW Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients J Transl Med 2020 18 160 10.1186/s12967-020-02323-x Open DOISearch in Google Scholar

[21] Lin P, He RQ, Dang YW, Wen DY, Ma J, He Y, et al. An autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients. Oncotarget. 2018; 9:17368–95. LinP HeRQ DangYW WenDY MaJ HeY An autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients Oncotarget 2018 9 17368 95 Search in Google Scholar

[22] Huang Z, Liu J, Luo L, Sheng P, Wang B, Zhang J, Peng SS. Genome-wide identification of a novel autophagy-related signature for colorectal cancer. Dose Response. 2019; 17:1559325819894179. doi: 10.1177/1559325819894179 HuangZ LiuJ LuoL ShengP WangB ZhangJ PengSS Genome-wide identification of a novel autophagy-related signature for colorectal cancer Dose Response 2019 17 1559325819894179 10.1177/1559325819894179 Open DOISearch in Google Scholar

[23] Lin QG, Liu W, Mo YZ, Han J, Guo ZX, Zheng W, et al. Development of prognostic index based on autophagy-related genes analysis in breast cancer. Aging (Albany NY). 2020; 12:1366–76. LinQG LiuW MoYZ HanJ GuoZX ZhengW Development of prognostic index based on autophagy-related genes analysis in breast cancer Aging (Albany NY) 2020 12 1366 76 Search in Google Scholar

[24] Zhu FX, Wang XT, Zeng HQ, Yin ZH, Ye ZZ. A predicted risk score based on the expression of 16 autophagy-related genes for multiple myeloma survival. Oncol Lett. 2019; 18:5310–24. ZhuFX WangXT ZengHQ YinZH YeZZ A predicted risk score based on the expression of 16 autophagy-related genes for multiple myeloma survival Oncol Lett 2019 18 5310 24 Search in Google Scholar

[25] McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C. Cancer chromosomal instability: therapeutic and diagnostic challenges. EMBO Rep. 2012; 13:528–38. McGranahanN BurrellRA EndesfelderD NovelliMR SwantonC Cancer chromosomal instability: therapeutic and diagnostic challenges EMBO Rep 2012 13 528 38 Search in Google Scholar

[26] Bakhoum SF, Cantley LC. The multifaceted role of chromosomal instability in cancer and its microenvironment. Cell. 2018; 174:1347–60. BakhoumSF CantleyLC The multifaceted role of chromosomal instability in cancer and its microenvironment Cell 2018 174 1347 60 Search in Google Scholar

[27] Engelhardt M, Terpos E, Kleber M, Gay F, Wäsch R, Morgan G, et al. European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma. Haematologica. 2014; 99:232–42. EngelhardtM TerposE KleberM GayF WäschR MorganG European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma Haematologica 2014 99 232 42 Search in Google Scholar

[28] Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, et al. Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol. 2015; 33:2863–9. PalumboA Avet-LoiseauH OlivaS LokhorstHM GoldschmidtH RosinolL Revised international staging system for multiple myeloma: a report from international myeloma working group J Clin Oncol 2015 33 2863 9 Search in Google Scholar

[29] Neben K, Jauch A, Bertsch U, Heiss C, Hielscher T, Seckinger A, et al. Combining information regarding chromosomal aberrations t(4;14) and del(17pl3) with the international staging system classification allows stratification of myeloma patients undergoing autologous stem cell transplantation. Haematologica. 2010; 95:1150–7. NebenK JauchA BertschU HeissC HielscherT SeckingerA Combining information regarding chromosomal aberrations t(4;14) and del(17pl3) with the international staging system classification allows stratification of myeloma patients undergoing autologous stem cell transplantation Haematologica 2010 95 1150 7 Search in Google Scholar

[30] Kalff A, Spencer A. The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies. Blood Cancer J. 2012; 2:e89. doi: 10.1038/bcj.2012.37 KalffA SpencerA The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies Blood Cancer J 2012 2 e89 10.1038/bcj.2012.37 Open DOISearch in Google Scholar

[31] Mei H, Xiang Y, Mei H, Fang B, Wang Q, Cao D, et al. Pterostilbene inhibits nutrient metabolism and induces apoptosis through AMPK activation in multiple myeloma cells. Int J Mol Med. 2018; 42:2676–88. MeiH XiangY MeiH FangB WangQ CaoD Pterostilbene inhibits nutrient metabolism and induces apoptosis through AMPK activation in multiple myeloma cells Int J Mol Med 2018 42 2676 88 Search in Google Scholar

[32] Desantis V, Saltarella I, Lamanuzzi A, Mariggiò MA, Racanelli V, Vacca A, Frassanito MA. Autophagy: a new mechanism of prosurvival and drug resistance in multiple myeloma. Transl Oncol. 2018; 11:1350–7. DesantisV SaltarellaI LamanuzziA MariggiòMA RacanelliV VaccaA FrassanitoMA Autophagy: a new mechanism of prosurvival and drug resistance in multiple myeloma Transl Oncol 2018 11 1350 7 Search in Google Scholar

[33] Rozental A, Gafter-Gvili A, Vidal L, Raanani P, Gurion R. The role of maintenance therapy in patients with diffuse large B cell lymphoma: a systematic review and meta-analysis. Hematol Oncol. 2019; 37:27–34. RozentalA Gafter-GviliA VidalL RaananiP GurionR The role of maintenance therapy in patients with diffuse large B cell lymphoma: a systematic review and meta-analysis Hematol Oncol 2019 37 27 34 Search in Google Scholar

[34] Ayna G, Krysko DV, Kaczmarek A, Petrovski G, Vandenabeele P, Fésüs L. ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages. PLoS One. 2012; 7:e40069. doi: 10.1371/journal.pone.0040069 AynaG KryskoDV KaczmarekA PetrovskiG VandenabeeleP FésüsL ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages PLoS One 2012 7 e40069 10.1371/journal.pone.0040069 Open DOISearch in Google Scholar

[35] Lamy L, Ngo VN, Emre NC, Shaffer AL 3rd, Yang Y, Tian E, et al. Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell. 2013; 23:435–49. LamyL NgoVN EmreNC ShafferAL3rd YangY TianE Control of autophagic cell death by caspase-10 in multiple myeloma Cancer Cell 2013 23 435 49 Search in Google Scholar

[36] Pullarkat V, Meng Z, Donohue C, Yamamoto VN, Tomassetti S, Bhatia R, et al. Iron chelators induce autophagic cell death in multiple myeloma cells. Leuk Res. 2014; 38:988–96. PullarkatV MengZ DonohueC YamamotoVN TomassettiS BhatiaR Iron chelators induce autophagic cell death in multiple myeloma cells Leuk Res 2014 38 988 96 Search in Google Scholar

[37] Petrovski G, Ayna G, Majai G, Hodrea J, Benko S, Mádi A, Fésüs L. Phagocytosis of cells dying through autophagy induces inflammasome activation and IL-1β release in human macrophages. Autophagy. 2011; 7:321–30. PetrovskiG AynaG MajaiG HodreaJ BenkoS MádiA FésüsL Phagocytosis of cells dying through autophagy induces inflammasome activation and IL-1β release in human macrophages Autophagy 2011 7 321 30 Search in Google Scholar